DISTRIBUTION AND DISTRIBUTION RECORDS

Slides:



Advertisements
Similar presentations
Basic Principles of GMP
Advertisements

Chapter 14 Audit of the Sales and Collection Cycle
Chapter 2. Customer service The group of utilities or benefits the customer expects from the supplier.
Presentation #15 Prescription Drug Storage and Inventory.
 Prepared by: Paras Shah  Guided by: Dhaval Rathod.
1 MANUFACTURING AND PRODUCTION OF BIOLOGICAL PRODUCTS (ERT 455) HAZARD ANALYSIS AND CRITICAL CONTROL POINT (HACCP) SYSTEM Munira Mohamed Nazari School.
All You Never Wanted to Know About GLP and GMP
Collecting and Reporting Accounting Information Design of an effective AIS begins by considering outputs from the system. Outputs of an AIS include: 1.
Quality control of raw materials In-process control
Reference, Retention and Reserve Samples
Sales/Collection Process
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Documentation –Part 2 Basic Principles of GMP Pharmaceutical Quality,
World Health Organization
Presentation #18 Drug Recalls Drug recalls must be reviewed by the Department and forwarded to the appropriate manager at the LHD. The manager shall.
Centralized Sterile Product Preparation Workflow for Anywhere Health System (AHS)
Introduction Business Process Fundamentals
The Systems House, Inc. 06/11/12. Setup Drug Types, Pharma Records Pedigree Printing Options Pedigree How it Works Updating Reporting ARCOS Reporting.
FEDIAF Guide to Good Practice for the Manufacture of Safe Pet Food TRAINING PACKAGE Module IV Traceability.
Inspection Issues in the Analytical Laboratory: An FDA Perspective Yvonne McKnight Chemist US Food and Drug AdministrationPhone: x
Good Manufacturing Practice. Good Manufacturing Practice Regulations Establishes minimum GMP for methods to be used, and the facilities or controls to.
© 2006 Prentice Hall Business Publishing Accounting Information Systems, 10/e Romney/Steinbart1 of 96 C HAPTER 17 Special Topics in REA Modeling for the.
SAP ERP Sales and Distribution Solutions
Important informations
PACKAGING AND LABELING CONTROL
Aloe Vera of America: A Quality IASC-Certified Producer of Aloe Vera Presented by Walt Jones.
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
AT&L / Logistics & Material Readiness Office of Deputy Assistant Secretary (Supply Chain Integration) Government Furnished Materiel Requisitions GFP Working.
Chapter 13: Marketing Channels 1 Copyright Cengage Learning 2013 All Rights Reserved.
Final Rule for Preventive Controls for Animal Food 1 THE FUTURE IS NOW.
University of Southern California Enterprise Wide Information Systems Customer Order Management Instructor: Richard W. Vawter.
Module 2Slide 1 of 26 WHO - EDM Quality Management Basic Principles of GMP Part One.
DISTRIBUTION Distribution can be defined as an operation, or a series of operations, which physically bring goods manufactured or produced by any particular.
Spesification of raw material, intermediate and final product Prepared by: Paras Shah Guided by : Dhaval Rathod.
Good Manufacturing Practice (GMP) Compliance: GMPs EXPLAINED.
 CHANNELS OF DISTRIBUTION  DISTRIBUTION STRATEGY  SUPPLY CHAIN MANAGEMENT/LOGISTICS Place (Distribution)
Quality Control significance in pharmaceutical industry
Audit of the Sales and Collection Cycle. Identify the accounts and the classes of transactions in the sales and collection cycle. Describe the business.
Regulatory Labeling and Marketing. Which ones are involved in label design and control? Manufacturing Manufacturing Quality Assurance Quality Assurance.
Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.
Supply Chain Management Chapter Definition of Supply Chain Management Supply Chain Management refers to the effort to coordinate suppliers, manufacturers,
IP Accountability in Outpatient Clinical Trials Jessica Rinaldi, CCRP Farber Institute for Neurosciences.
Insulating Glass Manufacturing Quality Procedure Manual TM (07)
LABORATORY SAMPLES AND CONTRACT MANAGEMENT
Customer Order and Account Management Business Processes Chapter 7.
Chapter 14 Inventory Control.
Problem 14-21, p. 490, 11th. Canadian Edition
Make-to-Stock Scenario Overview
Questions LO 3: Explain the role of three types of tests in the audit of inventory. Discussion problems: questions or
Problem 9-3, Page 473 Key Control, Control Test Evaluation
Field Inventory Services-Sanofi Inventory and Audit Training
Documentation –Part 2 Basic Principles of GMP Pharmaceutical Quality,
Global Distribution and Logistics
Make-to-Stock Scenario Overview
Introduction to GMP.
Quality Management Systems – Requirements
Best Practices in Maintaining Personnel Files
Sales Order Process.
Merchandising EOPA Study Guide.
Developing a Recall Plan for Meat and Poultry Products
Sales/Collection Process
Understanding Back-End Systems
World Health Organization
Order procurement Input: customer need Sales: identifies customer need
Complaints and Recalls
County Wide Safety Program
Ch 18: Pharmacy.
Physical Distribution
Accounting Information Systems and Business Processes - Part I
Radiopharmaceutical Production
Presentation transcript:

DISTRIBUTION AND DISTRIBUTION RECORDS PREPARED BY : Paras Shah M.pharm sem-1 Quality assurance GUIDED BY : Mr. DHAVAL RATHOD

DISTRIBUTION PROCEDURES Written procedures shall be established, and followed, describing the distribution of drug products. They shall include: 1. A procedure whereby the oldest approved stock of a drug product is distributed first. Deviation from this requirement is permitted if such deviation is temporary and appropriate. 2. A system by which the distribution of each lot of drug product can be readily determined to facilitate its recall if necessary.

Distribution records must be constructed and procedures established to facilitate recall of defective product. A requisite of the system is approval and specific release of each lot of drug by the quality control function before distribution can occur. This control of finished goods for shipment allows only those drugs into commerce that have been shown by testing to confirm to appropriate requirements. The manufacture must maintain records of all distribution transactions involving in-process or finished goods. All records should be indexed by either the manufacturing batch-lot number of the packaging control number as a means of accountability until the shipment passes from the direct control of the manufacturer.

This type of indexing permits an efficient determination of the receiver of a lot to be recalled since only one shipment record need be examined. Depending on the marketing procedure of the individual company, distribution records may list shipments to consignees for packaging or labeling, or to an independent distributor, a wholesaler, a retail pharmacist, a physician, or possibly the ultimate consumer. A variety of distribution recording systems may be utilized. Two of the more commonly used approaches are 1. To record the lot or control number on the retained copies of the shipping invoices 2. To record the dates on which each lot commenced distribution.

This later approach has disadvantages in that it does not readily accommodate the redistribution of small amounts of returned goods or the occasional need to distribute part lots out of sequence. Many U.S. companies also distribute products to their foreign affiliates. The distribution records should also include these transactions. This can become complicated if distribution from the United States is to a central international distribution center and the U.S. operation has no records of the final distribution. In these situations the U.S. QA function should evaluate and audit the central international distribution center operation and confirm the adequacy of its systems and controls.

The distribution process also includes other considerations The distribution process also includes other considerations. It must be arranged so that a first in/ first out movement of product occurs. This requirement is consistent with the intent of the stability and expiration dating policy. The distribution system must include provisions in order that this movement is achieved. Exceptions to this requirement that may be permitted should be described in written procedures. All distribution records should be maintained for a minimum 3-year period after the distribution process for any control number has been completed. If expiration date is used for a product, distribution records must be maintained at least for 1 year past the expiration date of the product.

DISTRIBUTION RECORDS Distribution records shall contain the name and strength of the product and description of the dosage form, name and address of the consignee, date and quality shipped, and lot or control number of the drug product. For compressed medical gas products, distribution records are not required to contain lot or control numbers. The primary purpose is to ensure that adequate data are available to access trade customers should a recall be initiated. The recording of lot number to each order will certainly accomplish this purpose.

The recordings of dates on which a specific lot of product commenced and ceased distribution may be used. All customers receiving the product between these dates could then be contacted. Obviously on the first and last days of distribution, some of the customers may have received product from the end of previous lot or the beginning of the next lot. This overlap should in no way adversely impact on the effectiveness of a recall. Whatever system is used, it must accommodate the reintroduction of returned goods into the distribution chain.

Distribution records include a wide range of documentation such as invoices, bills of lading, customers’ receipts, internal warehouse storage and inventory records. The information required need not be on every document. Also customer codes and product codes may be used as alternates to customer names and address and product names.